The Cancer Letter

Inside information on cancer research and drug development

Vol.
28
No.
5
May 27, 2005May 27, 2005
Free
DOWNLOAD THE PDF

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

Dietary Interventions Reduce Breast Cancer Risk In Trials

Novel Treatment Modalities Tested Against Bladder Cancer

Center And Cooperative Group Clinical Trials Approved By NCI

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account